{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:25:07Z","timestamp":1791321907222,"version":"4.3.1"},"reference-count":22,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24tm0424221h0004"],"award-info":[{"award-number":["24tm0424221h0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23KC2002"],"award-info":[{"award-number":["23KC2002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Hum Lact"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Treatment for mental disorders in pregnant and lactating mothers is beneficial for both mothers and children. The potential effects of drugs used for mental health care during pregnancy and lactation on the fetus, neonate, and infant have not been fully elucidated for all drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main issue:<\/jats:title>\n                    <jats:p>Information on placental transfer, transfer into breast milk, and outcomes for newborns and infants born to mothers who used bromazepam during the perinatal period is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Management:<\/jats:title>\n                    <jats:p>Three cases in women aged 20 to 40 (one case of bromazepam monotherapy, one case of concomitant zolpidem therapy, and one case of concomitant sertraline therapy) used bromazepam during pregnancy and lactation, and maternal serum and breast milk concentrations of bromazepam were measured through non-interventional sampling. Bromazepam cord blood concentrations were evaluated in two cases and were similar to maternal serum concentrations. Bromazepam elimination from breast milk was similar to elimination from maternal blood. The relative infant dose calculated from breast milk concentrations obtained from lactating women taking 3\u20136\u2009mg of bromazepam daily ranged from 1.1% to 3.9%. All infants (whose feeding amounts were unknown and who were primarily formula-fed) were healthy, and no issues were identified during their 1-month and 3-month checkups. In the case of zolpidem co-administration, there was an emergency visit after discharge due to reduced crying, but there were no clinical problems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Bromazepam transfers into the placenta and breast milk, with no serious outcomes in neonates and infants, but one infant had unexplained lethargy. Further cases are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08903344261425429","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:13:11Z","timestamp":1774289591000},"page":"485-491","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Transfer of Bromazepam to Cord Blood and Breast Milk: A Case Series of Bromazepam Serum Levels and Outcomes in Newborns and Breastfed Infants"],"prefix":"10.1177","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4799-5562","authenticated-orcid":false,"given":"Jumpei","family":"Saito","sequence":"first","affiliation":[{"name":"Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9674-4310","authenticated-orcid":false,"given":"Rina","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Sandaiji","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyo","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Obstetrics, and Center for Maternal-Fetal, Neonatal, and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5277-9624","authenticated-orcid":false,"given":"Yuka Sano","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3411-5896","authenticated-orcid":false,"given":"Kayoko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-9275","authenticated-orcid":false,"given":"Mikako","family":"Goto","sequence":"additional","affiliation":[{"name":"Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, Tokyo, Japan"},{"name":"Integrated Center for Women\u2019s Health, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Akabane","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"Apotex Inc. (2022). Bromazepam tablets product monograph. https:\/\/pdf.hres.ca\/dpd_pm\/00064795.PDF"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","unstructured":"Chan A. Y. L. Gao L. Howard L. M. Simonoff E. Coghill D. Ip P. Lau W. C. Y. Taxis K. Wong I. C. K. Man K. K. C. (2023). Maternal Benzodiazepines and Z-drugs use during pregnancy and adverse birth and neurodevelopmental outcomes in offspring: A population-based cohort study. Psychother Psychosom 92(2) 113\u2013123. https:\/\/doi.org\/10.1159\/000529141","DOI":"10.1159\/000529141"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","unstructured":"Furugen A. Nishimura A. Kobayashi M. Umazume T. Narumi K. Iseki K. (2019). Quantification of eight benzodiazepines in human breastmilk and plasma by liquid-liquid extraction and liquid-chromatography tandem mass spectrometry: Application to evaluation of alprazolam transfer into breastmilk. Journal of Pharmaceutical and Biomedical Analysis 168 83\u201393. https:\/\/doi.org\/10.1016\/j.jpba.2019.02.011","DOI":"10.1016\/j.jpba.2019.02.011"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","unstructured":"Greenblatt D. J. Shader R. I. Divoll M. Harmatz J. S. (1981). Benzodiazepines: A summary of pharmacokinetic properties. British Journal of Clinical Pharmacology 11(Suppl. 1) 11S\u201316S. https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb01833.x","DOI":"10.1111\/j.1365-2125.1981.tb01833.x"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","unstructured":"Grigoriadis S. Graves L. Peer M. Mamisashvili L. Dennis C. L. Vigod S. N. Steiner M. Brown C. Cheung A. Dawson H. Rector N. Guenette M. Richter M. (2019). Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: Systematic review and meta-analysis. The Journal of Clinical Psychiatry 80(4) 18r12412. https:\/\/doi.org\/10.4088\/JCP.18r12412","DOI":"10.4088\/JCP.18r12412"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","unstructured":"Grigoriadis S. Graves L. Peer M. Mamisashvili L. Ruthirakuhan M. Chan P. Hennawy M. Parikh S. Vigod S. N. Dennis C. L. Steiner M. Brown C. Cheung A. Dawson H. Rector N. Guenette M. Richter M. (2020). Pregnancy and delivery outcomes following benzodiazepine exposure: A systematic review and meta-analysis. Canadian Journal of Psychiatry 65(12) 821\u2013834. https:\/\/doi.org\/10.1177\/0706743720904860","DOI":"10.1177\/0706743720904860"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","unstructured":"Howard L. M. Khalifeh H. (2020). Perinatal mental health: A review of progress and challenges. World Psychiatry 19(3) 313\u2013327. https:\/\/doi.org\/10.1002\/wps.20769","DOI":"10.1002\/wps.20769"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","unstructured":"Huitfeldt A. Sundbakk L. M. Skurtveit S. Handal M. Nordeng H. (2020). Associations of maternal use of benzodiazepines or benzodiazepine-like hypnotics during pregnancy with immediate pregnancy outcomes in Norway. JAMA Network Open 3(6) e205860. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.5860","DOI":"10.1001\/jamanetworkopen.2020.5860"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","unstructured":"Iqbal M. M. Sobhan T. Ryals T. (2002). Effects of commonly used benzodiazepines on the fetus the neonate and the nursing infant. Psychiatric Services 53(1) 39\u201349 https:\/\/doi.org\/10.1176\/appi.ps.53.1.39.","DOI":"10.1176\/appi.ps.53.1.39"},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","unstructured":"Jacqz-Aigrain E. Choonara I. (Eds.). (2021). Drugs in pregnancy and lactation. In: Paediatric clinical pharmacology (pp. 275\u2013362). CRC Press https:\/\/doi.org\/10.1201\/9780367800666.","DOI":"10.1201\/9780367800666"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","unstructured":"Kaplan S. A. Jack M. L. Weinfeld R. E. Glover W. Weissman L. Cotler S. (1976). Biopharmaceutical and clinical pharmacokinetic profile of bromazepam. Journal of Pharmacokinetics and Biopharmaceutics 4(1) 1\u201316. https:\/\/doi.org\/10.1007\/BF01271440","DOI":"10.1007\/BF01271440"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00063110-199406000-00008"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"Meng L. C. Lin C. W. Chuang H. M. Chen Y. Y. Shang C. Y. Wu C. Y. Chen L. K. Hsiao F. Y. (2024). Prescription patterns and predisposing factors of benzodiazepine and Z-hypnotic use during pregnancy: A nationwide cohort study. Pharmacoepidemiology and Drug Safety 33(6) e5847. https:\/\/doi.org\/10.1002\/pds.5847","DOI":"10.1002\/pds.5847"},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","unstructured":"Munger Clary H. M. (2024). Caution: Benzodiazepines in pregnancy and risk of adverse perinatal outcomes. Epilepsy Currents 24(2) 105\u2013107. https:\/\/doi.org\/10.1177\/15357597241227656","DOI":"10.1177\/15357597241227656"},{"issue":"4","key":"e_1_3_2_16_1","first-page":"239","article-title":"Perinatal depression: Implications for child mental health","volume":"7","author":"Muzik M.","year":"2010","unstructured":"Muzik M., Borovska S. (2010). Perinatal depression: Implications for child mental health. Mental Health in Family Medicine, 7(4), 239\u2013247.","journal-title":"Mental Health in Family Medicine"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","unstructured":"Nielsen A. M. Stika C. S. Wisner K. L. (2025). Perinatal psychiatry: Balancing maternal-fetal exposures to mental disorders and drug treatments. Seminars in Perinatology 49(4) 152076. https:\/\/doi.org\/10.1016\/j.semperi.2025.152076","DOI":"10.1016\/j.semperi.2025.152076"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","unstructured":"Ochs H. R. Greenblatt D. J. Friedman H. Burstein E. S. Locniskar A. Harmatz J. S. Shader R. I. (1987). Bromazepam pharmacokinetics: Influence of age gender oral contraceptives cimetidine and propranolol. Clinical Pharmacology and Therapeutics 41(5) 562\u2013570. https:\/\/doi.org\/10.1038\/clpt.1987.72","DOI":"10.1038\/clpt.1987.72"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","unstructured":"Oo C. Y. Kuhn R. J. Desai N. Wright C. E. McNamara P. J. (1995). Pharmacokinetics in lactating women: Prediction of alprazolam transfer into milk. British Journal of Clinical Pharmacology 40(3) 231\u2013236. https:\/\/doi.org\/10.1111\/j.1365-2125.1995.tb05778.x","DOI":"10.1111\/j.1365-2125.1995.tb05778.x"},{"key":"e_1_3_2_20_1","unstructured":"Roche Products PTY Limited. (2012). Lexotan. Dee Why NSW. https:\/\/e-lactancia.org\/media\/papers\/Bromazepam-DS-2012.pdf"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","unstructured":"Saito J. Tachibana Y. Wada Y. S. Yakuwa N. Kawasaki H. Suzuki T. Sago H. Yamatani A. Murashima A. (2022). Transfer of brotizolam periciazine and sulpiride in cord blood and breast milk and alprazolam in breast milk: A case report. Journal of Pharmaceutical Health Care and Sciences 8(1) 10. https:\/\/doi.org\/10.1186\/s40780-022-00241-2.","DOI":"10.1186\/s40780-022-00241-2"},{"issue":"6","key":"e_1_3_2_22_1","first-page":"638","article-title":"Medication safety in breastfeeding","volume":"106","author":"Spencer J. P.","year":"2022","unstructured":"Spencer J. P., Thomas S., Trondsen Pawlowski R. H. (2022). Medication safety in breastfeeding. American Family Physician, 106(6), 638\u2013644.","journal-title":"American Family Physician"},{"key":"e_1_3_2_23_1","doi-asserted-by":"crossref","unstructured":"Weisskopf E. Panchaud A. Nguyen K. A. Grosjean D. Hasco\u00ebt J. M. Csajka C. Eap C. B. Ansermot N. (2017). Simultaneous determination of selective serotonin reuptake inhibitors and their main metabolites in human breast milk by liquid chromatography-electrospray mass spectrometry. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 1057 101\u2013109. https:\/\/doi.org\/10.1016\/j.jchromb.2017.04.039","DOI":"10.1016\/j.jchromb.2017.04.039"}],"container-title":["Journal of Human Lactation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08903344261425429","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08903344261425429","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08903344261425429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:52:40Z","timestamp":1781787160000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08903344261425429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/08903344261425429"],"URL":"https:\/\/doi.org\/10.1177\/08903344261425429","relation":{},"ISSN":["0890-3344","1552-5732"],"issn-type":[{"value":"0890-3344","type":"print"},{"value":"1552-5732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}